CERTARA INC. - COMMON STOCK
11.09
04-October-24 14:59:59
15 minutes delayed
Stocks
+0.10
+0.91%
Today's range
11.06 - 11.39
ISIN
N/A
Source
NASDAQ
-
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 Oct 2022 06:45:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
31 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara Announces Secondary Offering
11 Aug 2022 15:38:42 By Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2022 Financial Results
09 Aug 2022 15:15:01 By Nasdaq GlobeNewswire
-
Certara Introduces Update of Pinnacle 21™ Enterprise and New Pinnacle 21™ Data Exchange Module
05 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies
28 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara Appoints Rosemary Crane as New Independent Board Member
25 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Certara Appoints Eran Broshy as New Independent Board Member
13 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 Jul 2022 07:00:01 By Nasdaq GlobeNewswire
-
28 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
21 Jun 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2022 Financial Results
05 May 2022 15:15:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
03 May 2022 15:30:00 By Nasdaq GlobeNewswire
-
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 Mar 2022 15:15:00 By Nasdaq GlobeNewswire
-
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 Feb 2022 15:30:00 By Nasdaq GlobeNewswire
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
15 Feb 2022 15:30:00 By Nasdaq GlobeNewswire
-
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
08 Feb 2022 15:30:00 By Nasdaq GlobeNewswire
-
21 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Certara Announces Release of Pinnacle 21 Enterprise Software
13 Dec 2021 07:00:01 By Nasdaq GlobeNewswire